Mutations in the RAS/MAPK Pathway Drive Replication Repair–Deficient Hypermutated Tumors and Confer Sensitivity to MEK Inhibition
Brittany Campbell(Hospital for Sick Children), Uri Tabori(Universität Hamburg)
Cited by 39
Related Papers
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
|Nature Genetics|2014|654
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas
|Cancer Cell|2020|470
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
|The Lancet Oncology|2013|404